Skip to main content
. Author manuscript; available in PMC: 2020 Oct 15.
Published in final edited form as: J Immunol. 2019 Sep 11;203(8):2319–2327. doi: 10.4049/jimmunol.1900254

FIG 2.

FIG 2.

IL-25 signaling in CD11c+ cells promotes HDM-induced type-2 inflammatory mediators. (A) Protein levels of IL-9, IL-13 in BALF and CCL17 in lungs of WT and mutant mice as indicated after HDM (or PBS) exposures. (B) Relative mRNA levels of IL9, IL13 and CCL17 in lungs as in (A). Significance indicated for HDM-treated WT vs KO mice. Data are the mean ± sem of two independent experiments with a total of n=6–8 mice per group for WT and IL-17RB CD11c KO and n=6–12 mice per group for WT and CIKS CD11c KO. *p<0.05; **p<0.01.